The '''Hematological Cancer Research Investment and Education Act of 2001''' (P.L. 107-172) amends the [[Public Health Service Act]] to allocate funding and establish directed research and education programs targeted at forms of [[blood cancer]], in particular [[leukemia]], [[lymphoma]], and [[multiple myeloma]].<ref name="olpa">{{cite web | url=http://olpa.od.nih.gov/legislation/107/publiclaws/hematological.asp | title=Legislative Updates: Hematological Cancer Research Investment and Education Act of 2001 | publisher=[[Office of Legislative Policy and Analysis]] | accessdate=June 24, 2009}}</ref>

The bill was introduced as S. 1094 by Senator [[Kay Bailey Hutchison]] of Texas in June 2001.  Hutchinson's brother has had multiple myeloma and she worked for several years to pass legislation of this type.<ref name="mmrf"/>  The bill came out through the [[Senate Committee on Health, Education, Labor, and Pensions]], and passed the [[United States Senate]] by unanimous consent in November 2001.  It went through the [[House Committee on Energy and Commerce]] and passed the [[U.S. House of Representatives]] on a voice vote in April 2002.  It was signed into law by President [[George W. Bush]] on May 14, 2002.<ref name="olpa"/>

The research part of the bill, the Joe Moakley Research Excellence Program, requires the Director of the [[National Institutes of Health]], through the [[National Cancer Institute]], to expand and coordinate blood cancer research programs.<ref name="olpa"/>  It was named after former Massachusetts Congressman [[Joe Moakley]], who died in May 2001 of [[myelodysplastic syndrome]], a form of leukemia.<ref>{{cite news | url=http://www.boston.com/news/daily/28/moakley_obit.htm | title=John Joseph Moakley dies at age 74 | author=Feeney, Mark | publisher=''[[The Boston Globe]]'' | date=May 28, 2001}}</ref>  The education part of the bill, the Geraldine Ferraro Cancer Education Program, requires the [[Secretary of Health and Human Services]] to establish an education program for patients of such blood cancers and the general public.<ref name="olpa"/>  It is named after former New York Congresswoman and 1984 Democratic vice-presidential nominee [[Geraldine Ferraro]], who has been battling multiple myeloma since 1998.<ref name="cr-f2007">{{cite news | url=http://www.crmagazine.org/archive/Fall2007/Pages/APublicLifeWithCancer.aspx | title=A Public Life With Cancer | publisher=[[CR (magazine)|''CR'' magazine]] | date=Fall 2007 | author=Gorman, Jessica}}</ref>  Ferraro did not publicly disclose her disease until June 2001, when she appeared in Congressional hearings to advocate for passage of the Act.<ref name="cr-f2007"/>

An example of the Moakley program funding is $12.75 million to [[The University of Texas M. D. Anderson Cancer Center]].<ref name="utacc">{{cite web | url=http://www.mdanderson.org/education-and-research/research-at-md-anderson/early-detection-and-treatment/research-programs/spores/leukemia-spore/index.html | title=The Joe Moakley Leukemia SPORE | publisher=[[The University of Texas M. D. Anderson Cancer Center]] | accessdate=June 24, 2009}}</ref>  The Ferraro program was not funded in 2003,<ref name="utacc"/> but received $5 million funding in 2004.<ref name="mmrf">{{cite press release | url=http://www.multiplemyeloma.org/in_the_news/6.03.007.php | title=The Multiple Myeloma Research Foundation Congratulates and Supports Senator Kay Bailey Hutchsion for Her Commitment to Blood Disease Research and Education | publisher=[[Multiple Myeloma Research Foundation]] | date=March 24, 2004}}</ref>

==References==
{{reflist}}

[[Category:2002 in law]]
[[Category:United States federal health legislation]]
[[Category:United States Department of Health and Human Services]]
[[Category:National Institutes of Health]]